We did not find any evidence that the tested genetic variants in CDH1 (rs16260), IGFBP3 (rs2854744), VEGF (rs1570360) and STK15 (rs2273535) influenced risk of RCC in VHL disease patients. Here, IGFBP3 is linked to renal cell carcinoma.